Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition
Hemophilia A patients manage the chronic disorder with infusions administered as frequently as every two to three days. The FDA has approved a Sanofi drug designed to last longer in the body, giving patients…
Continue Reading